SEC Form 4 research
| Issuer | Xilio Therapeutics, Inc. |
|---|---|
| Tickers | XLO |
| Reporting owners | 60 |
| Officers and directors | 3 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Houvras Yariv | A | 105,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.